When the positivity of PD-L1 expression on only tumor cells was considered, the KEYNOTE-040 study using the TPS demonstrated that a higher cut-off value for TPS (≥50%) was also linked to a significantly better clinical outcome [51]. Here, CD274 is linked to neoplasm.